Boston Scientific (BSX) Q1 2026 Forecast: Anticipated EPS of $0.79, Reflecting Year-Over-Year Growth

Earnings Expectations: Analysts predict Boston Scientific Corporation will report earnings of $0.79 per share and revenue of $5.17 billion for Q1 2026, reflecting modest growth expectations.

Recent Trends: The consensus EPS estimate has slightly declined by 1.3% over the past 90 days, indicating tempered near-term outlooks, while revenue forecasts suggest stable expectations for the medical device manufacturer.

Year-over-Year Comparisons: Year-over-year comparisons show a revenue growth of 10.9% from $4.66 billion, highlighting the company's ability to sustain volume and pricing gains across its medical device portfolio.

Market Sentiment: Mixed sentiment surrounds medical device stocks, influenced by valuation multiples, reimbursement pressures, and the pace of innovation, which are critical factors for investors to monitor in upcoming earnings releases.